AHR antagonist 5 hemimaleate
AHR antagonist 5 hemimaleate is a potent, orally bioavailable aryl hydrocarbon receptor (AHR) inhibitor with an IC50 below 0.5 μM. It demonstrates synergistic antitumor activity in combination with anti-PD-1 therapy in preclinical models, making it a valuable tool for immuno-oncology and cancer metabolism research.
Product Specifications
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Molecular Formula
C29H28FN7O4
Molecular Weight
499.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15164728 1 Vial
Lentiviral mouse Srrm1 shRNA (UAS) - Lentiviral mouse Srrm1 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
GTR15334592 1 Vial
Lentiviral human OR8B2 shRNA (UAS) - Lentiviral human OR8B2 shRNA (UAS) (25)
Sign In for Pricing
View Details K2344207 1.0 µg DNA
TBX2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details